Parenteral Nutrition
2
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Fresenius KabiGermany - Bad Homburg
2 programs2
SMOF lipid and IntralipidPhase 31 trial
SmofKabiven emulsion for infusionPhase 31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Fresenius KabiSmofKabiven emulsion for infusion
Fresenius KabiSMOF lipid and Intralipid
Clinical Trials (2)
Total enrollment: 348 patients across 2 trials
Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition
Start: Jan 2019Est. completion: Jan 2020273 patients
Phase 3Completed
Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition
Start: Oct 2007Est. completion: Nov 200875 patients
Phase 3Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space